Latest News


Systems Medicine Conference in Slovenia

Systems Medicine Conference in Slovenia: National Awareness Event,12th CFGBC Symposium and “Systems Medicine” Workshop took place from June 8th-9th 2017 at Hotel Slon, Ljubljana, Slovenia.

CASyM winter school of Systems Medicine

CASyM winter school of Systems Medicine took place between March 29th and April 1st 2017 in Ljubljana, Slovenia and is entitled »The 3rd SysBioMed hands-on tutorial: Systems Medicine Approaches in Personalized Medicine«

ELIXIR-SI launch & 11TH CFGBC Symposium

The event with motto “Data for Life” took place from September 20th - 21st 2016 at Cankarjev dom and the Faculty of Medicine, University of Ljubljana, Slovenia.


Familial Erythrocytosis: From Mutation Analysis to Clinical Application

Nataša Debeljak1, Irena Preložnik Zupan2

1Medical Center for Molecular Biology, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia, 2Clinical Department of Haematology, University Medical Centre Ljubljana, Slovenia

Erythrocytosis is heterogeneous group of disorders characterized by an increased mass of erythrocytes, hematocrit (Ht) and hemoglobin (Hb) in blood. It is caused by an inherited or acquired mutations or as a compensatory mechanism in some chronical disorders. Familial erythrocytosis (FE) is a group of rare congenital disorders with various genetic background [1]. Erythropoietin receptor gene (EPOR) mutations are the indicator for primary familial erythrocytosis. Secondary familial erythrocytosis syndromes are typically associated with a defect in various genes included in oxygen sensing pathway leading to the increased erythropoietin (EPO) production, such as Von Hippel-Lindau tumour suppressor (VHL) and endothelial PAS domain (EPAS1). Latest whole-genome sequencing identified at least 21 candidate genes and variants involved in FE [2].
Polycythemia vera (PV) is the most common acquired erythrocytosis caused by mutations in Janus kinase 2 (JAK2), routinely tested at University Medical Centre (UMC) Ljubljana and Maribor. Other genetic forms or FE are indicated as JAK2 negative and are not tested further. Recently, sequence variants of the EPO and EPOR gene associated with FE were identified and are in the process of integration into diagnostic procedures for FE in Slovenia [3].
The aim of the current study was to extend diagnostic procedures of JAK2 negative FE and develop additional diagnostic tests. Study will determine genetic variations and frequencies of erythrocytosis in Slovenian population in correlation with clinical picture.
Hussein K (2012) Eur J Hum Genet
Camps C et al. (2016) Haematol
Vočanec D et al. (2017) in preparation

2006 - University of Ljubljana, Faculty of Medicine, Center for Functional Genomics and Bio-chips.